April 2010
Volume 51, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2010
Effects of Etoposide in a Transgenic Murine Model of Retinoblastoma
Author Affiliations & Notes
  • P. J. Stewart
    University of California San Francisco, San Francisco, California
  • K. Ebrahimi
    Wilmer Eye Institute, Baltimore, Maryland
  • K. Van Quill
    University of California San Francisco, San Francisco, California
  • J. O'Brien
    University of California San Francisco, San Francisco, California
  • Footnotes
    Commercial Relationships  P.J. Stewart, None; K. Ebrahimi, None; K. Van Quill, None; J. O'Brien, None.
  • Footnotes
    Support  National Eye Institute RO1 Grant EY13812 and Core Grant EY02162; Wayne and Gladys Valley Foundation; Knights Templar Eye Foundation; Research to Prevent Blindness; That Man May See Foundation.
Investigative Ophthalmology & Visual Science April 2010, Vol.51, 2069. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      P. J. Stewart, K. Ebrahimi, K. Van Quill, J. O'Brien; Effects of Etoposide in a Transgenic Murine Model of Retinoblastoma. Invest. Ophthalmol. Vis. Sci. 2010;51(13):2069.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : The purpose of this study is to evaluate the effects of etoposide, as a single agent, in a transgenic murine model of retinoblastoma. Etoposide is routinely used as part of the combination chemotherapy given to children with retinoblastoma. Etoposide is associated with several adverse effects, including increasing the risk of acute myelocytic leukemia.

Methods: : LHß-TAg transgenic mice received either etoposide (20 mg/kg) or vehicle via single intraperitoneal injection three days a week for three weeks. The mice were then sacrificed three days after their last treatment and their eyes were serially sectioned and analyzed to assess tumor burden.

Results: : The ocular tumor burden in mice treated with etoposide did not significantly differ (p = 0.445) from that of mice treated with control.

Conclusions: : Etoposide as a single agent has no significant effect on retinoblastoma in a transgenic murine model. This finding raises the possibility that etoposide is not an effective chemotherapeutic agent for this disease, perhaps exposing children to unnecessary toxicity.

Keywords: retinoblastoma • tumors • retina 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×